Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|May 8, 2001
Ridogrel enemas in distal ulcerative colitisJ J Auwerda, F J Zijlstra, C J Tak, et al.The Journal of Clinical Investigation|February 1, 1996
Congenital sucrase-isomaltase deficiency. Identification of a glutamine to proline substitution that leads to a transport block of sucrase-isomaltase in a pre-Golgi compartmentJ Ouwendijk, C E Moolenaar, W J Peters, et al.The American Journal of Gastroenterology|July 14, 2000
Dysphagia lusoria: clinical aspects, manometric findings, diagnosis, and therapyM Janssen, M G Baggen, H F Veen, et al.Agents and Actions|January 1, 1992
15-HETE is the main eicosanoid formed by human colonic mucosaF J Zijlstra, A P van Dijk, J H Wilson, et al.Gut|April 1, 1996
Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillationF W Leebeek, R J Ouwendijk, A H Kolk, et al.Scandinavian Journal of Gastroenterology|March 1, 1988
Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, dazoxiben, and indomethacinB van Ooijen, R J Ouwendijk, W J Kort, et al.Journal of Cell Science|March 1, 1997
A mutation in a highly conserved region in brush-border sucrase-isomaltase and lysosomal alpha-glucosidase results in Golgi retentionC E Moolenaar, J Ouwendijk, M Wittpoth, et al.Biochimica Et Biophysica Acta|June 19, 1998
Analysis of a naturally occurring mutation in sucrase-isomaltase: glutamine 1098 is not essential for transport to the surface of COS-1 cellsJ Ouwendijk, W J Peters, R H te Morsche, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposureZuzana Zelinkova, Cokkie van der Ent, Karlien F Bruin, et al.Plos One|July 29, 2016
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab TherapyWilhelmina M C Timmermans, Jan A M van Laar, Tim B van der Houwen, et al.Pageof 4